patent/SU-1673969-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1673969-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff4785699bcb682fe2db1229b9ade62b
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
filingDate	1986-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	1991-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b87c1019c6a449be00de7efa434e103b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77687b4c32f69776c94a4bb303f6c91c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee7ca263b782236ce4d38f64e1fd4e6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cde660c4c2337af8385eb66ab976286 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12451bf976c05ee1842b5b2f87fbbd9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81a0d279f1f6e686aed0bf31a9396186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94190ff80e357d2845b6c076665c0870 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f56c96806601b09547e6b93762c736e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7c52defcdda05b265f05d3756621935 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1f80db91c7ee2ecd3e4a51e497e7660 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92fbc91391d96e5e38271931af85cc4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b43e99bfdb8a6b4792afcf96e5e2956 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91d5f7cca603941d7d7f7453dc8f08b9
publicationDate	1991-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	SU-1673969-A1
titleOfInvention	Method for production of suspension for reconstruction of liver membranes and cells
abstract	The invention relates to medicine, intended to create a drug for the treatment of liver diseases. The purpose of the invention is to increase the reparative effect of the suspension by mixing cotton phosphatidylcholine (FChl) and a liquor foaming agent (SP) detergent at a ratio of components (in mass parts) of 1: (0.1: 0.4) parts by weight. Then the mixture is treated with ultrasound in the mode of average power (180 W, frequency 30 kHz) for 6-10 minutes at 10 ° C. When the suspension becomes clear, the ultrasound is stopped. The suspension is used for membrane reconstruction.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-1171-Z
priorityDate	1986-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168614 http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID46348 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551227 http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID46348

Total number of triples: 29.